These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3995104)

  • 1. Chromatographic characterization of endogenous digoxin-like immunoreactive substances present in serum and urine of infants using gel filtration with Sephadex G 25.
    Clerico A; Boldrini A; Balzan S; Biver P; Fantoni M
    Biol Neonate; 1985; 47(4):217-22. PubMed ID: 3995104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal changes in a digoxin-like immunoreactive substance.
    Seccombe DW; Pudek MR; Whitfield MF; Jacobson BE; Wittmann BK; King JF
    Pediatr Res; 1984 Nov; 18(11):1097-9. PubMed ID: 6514436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the carrier protein of digoxin-like immunoreactive substance in plasma.
    Montali U; Balzan S; Ghione S
    J Hypertens Suppl; 1987 Dec; 5(5):S299-302. PubMed ID: 3481818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-like immunoreactivity in normal human plasma and urine, as detected by a solid-phase radioimmunoassay.
    Balzan S; Clerico A; Grazia del Chicca M; Montali U; Ghione S
    Clin Chem; 1984 Mar; 30(3):450-1. PubMed ID: 6697495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin-like immunoreactive substance in postmortem blood of infants and children.
    Spiehler VR; Fischer WR; Richards RG
    J Forensic Sci; 1985 Jan; 30(1):86-91. PubMed ID: 3981124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits.
    Pudek MR; Seccombe DW; Jacobson BE; Humphries K
    Clin Chem; 1985 Nov; 31(11):1806-10. PubMed ID: 4053349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.
    Yiannakou L; Loucari-Yiannakou E; Souvatzoglou A
    Clin Biochem; 1991 Dec; 24(6):475-82. PubMed ID: 1773487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of steroids to digoxin-like immunoreactivity in cord blood.
    Yun WS; Ho CS; Panesar NS; Swaminathan R
    Ann Clin Biochem; 1992 May; 29 ( Pt 3)():337-42. PubMed ID: 1319129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+, K+-ATPase.
    Diamandis EP; Papanastasiou-Diamandi A; Soldin SJ
    Clin Biochem; 1985 Feb; 18(1):48-55. PubMed ID: 2985294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
    Chicella M; Branim B; Lee KR; Phelps SJ
    Ther Drug Monit; 1998 Jun; 20(3):347-51. PubMed ID: 9631935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between digoxin-like immunoreactivity and electrolyte values in urinary samples of newborns.
    Clerico A; Boldrini A; Del Chicca MG; Biver P; Fantoni M; Mezzasalma L; Fassorra C; Cipolloni C
    Biol Neonate; 1986; 50(1):27-35. PubMed ID: 3755623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age and serum creatinine on endogenous digoxin-like substances in infants and children.
    Phelps SJ; Kamper CA; Bottorff MB; Alpert BS
    J Pediatr; 1987 Jan; 110(1):136-9. PubMed ID: 3540246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic activity of digoxin-like immunoreactive substance extracted from cord blood.
    Ebara H; Suzuki S; Nagashima K; Kuroume T
    Life Sci; 1988; 42(3):303-9. PubMed ID: 2826960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of endogenous digoxin-like immunoreacting activities to salt balance and renal function in man.
    Kramer HJ; Heppe M; Pennig J; Kipnowski J; Klingmüller D; Düsing R; Krück F
    Klin Wochenschr; 1985; 63 Suppl 3():107-10. PubMed ID: 2987606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
    Dasgupta A; Trejo O
    Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.